CSE/BUX (CSE/BUX)

Canadian Securities Exchange: CSE/BUX · CAD

CA$0.45

-0.02 (-4.3%)· Recorded snapshot

Market cap	44.3M
Revenue (ttm)	27.8K
Net income (ttm)	-1.4M
EPS (ttm)	-CA$0.01
Volume	4,757
Beta	-0.38

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 27.8K
Net income (ttm): -1.4M
EPS (ttm): -CA$0.01
Market cap: 44.3M

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector percentile context

Refreshed 2026-10-29 19:55 UTC

Forward P/En/a

P25 n/aP50 n/aP75 n/a

Trailing P/En/a

P25 n/aP50 n/aP75 n/a

ROE-149.9

P25 n/aP50 n/aP75 n/a

ROIC-52.4

P25 n/aP50 n/aP75 n/a

Benchmarks · 1M

All CSE/BUX indicators

Market & fundamental data

Available fields

168

Groups with data

Currency

CAD

Showing 168 of 168 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Amount currency	CAD
Country	Canada
Country code	CA
Earnings date	2026-11-27
Enterprise value	CAD 44.8M
Exchange	Canadian Securities Exchange
Financial currency	CAD
Financial report date	2026-06-30
First seen	2026-05-10
Fiscal year end	March
Founded	2014
Industry	Diagnostics & Research
Is primary listing	No
ISIN number	CA09073K1084
Last earnings date	2026-02-26
Last refreshed	2026-10-29
Market cap	CAD 44.3M
Next earnings date	2026-11-27
Price	CAD 0.45
Price currency	CAD
Sector	Healthcare
SIC code	2836
Stock price date	2026-10-29
Symbol	cse/BUX
Website	https://www.biomarkdiagnostics.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings yield	-2.88%
FCF / EV yield	-2.28%
FCF yield	-2.3%
P/B ratio	81.07x
P/S ratio	1,665.59x
Price / tangible book value	81.07x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
Gross margin	100%
Operating margin	-6,334.15%
Pretax margin	-5,127.11%
ROA	-45.63%
ROA (5Y)	-78.3%
ROCE	-117.49%
ROE	-149.87%
ROIC	-52.41%
SBC / revenue	139.06%

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
EPS growth quarters	5
EPS growth years	1
Gross profit growth	-82.05%
Gross profit growth (Q)	-82.03%
Gross profit growth 3Y	-43.88%
Net income growth quarters	2
Net income growth years	1
Revenue growth	-82.05%
Revenue growth (Q)	-82.03%
Revenue growth (QoQ)	0%
Revenue growth 3Y	-43.88%
Revenue growth years	0

Financial statements

Income-statement and cash-flow amounts, totals and per share.

Metric	Value
Capital expenditures	CAD -2,229
Depreciation and amortization	CAD 16,589
EBIT	CAD -1.8M
EBITDA	CAD -1.7M
EPS	CAD -0.01
Financing cash flow	CAD -240,120
Free cash flow	CAD -1.1M
Free cash flow minus SBC	CAD -1.1M
Gross profit	CAD 27,803
Investing cash flow	CAD 1.8M
Net borrowing	CAD -399,070
Net cash flow	CAD 517,905
Net income	CAD -1.4M
Operating cash flow minus SBC	CAD -1.1M
Operating income	CAD -1.8M
Revenue	CAD 27,803
Stock-based compensation	CAD 38,663

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Altman Z-Score	2.94
Book value per share	CAD 0.01
Debt / equity	2.23
Interest coverage	-22.76
Long-term assets	CAD 1.3M
Long-term liabilities	CAD 927,754
Net cash (debt)	CAD -482,899
Net cash / market cap	-1.04%
Net debt / equity	0.85
Piotroski F-Score	1
Property, plant and equipment	CAD 1.3M
Shareholders' equity	CAD 571,207
Tangible book value	CAD 571,207
Tangible book value per share	CAD 0.01
Total assets	CAD 2.2M
Total cash	CAD 788,323
Total debt	CAD 1.3M
Total liabilities	CAD 1.6M
WACC	2.26%

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Asset turnover	0.01
Current assets	CAD 861,250
Current liabilities	CAD 667,829
Current ratio	1.29
Net working capital	CAD -251,434
Quick ratio	1.26
Working capital	CAD 193,421
Working capital turnover	0.05

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback yield / dilution	-11.57%
Shareholder yield	-11.57%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y price change	542.86%
10Y return CAGR	20.45%
10Y total return	542.86%
150-day SMA	CAD 0.54
1D price change	-4.26%
1M price change	-18.18%
1M total return	-18.18%
1W price change	-4.26%
1W total return	-4.26%
1Y price change	32.35%
1Y return CAGR	32.38%
1Y total return	32.35%
20-day SMA	CAD 0.51
200-day SMA	CAD 0.50
3M price change	-18.18%
3M total return	-18.18%
3Y price change	63.64%
3Y return CAGR	17.84%
3Y total return	63.64%
50-day SMA	CAD 0.53
50-day SMA vs 200-day SMA	50over200
52-week high	CAD 0.64
52-week high date	2026-03-03
52-week low	CAD 0.32
52-week low date	2025-11-12
5Y price change	95.65%
5Y return CAGR	14.37%
5Y total return	95.65%
6M price change	-22.41%
6M total return	-22.41%
All-time high	CAD 0.64
All-time high date	2026-03-03
All-time low	CAD 0.03
All-time low date	2019-03-05
Average true range (ATR)	CAD 0.02
Average volume	6.9K
Beta (5Y)	-0.38
Change from 52-week high	-29.69%
Change from 52-week low	40.63%
Change from all-time high	-29.69%
Change from all-time low	1,400%
Change from open	-4.26%
Day's gap	0%
Dollar volume	CAD 2,141
High price	CAD 0.47
Low price	CAD 0.45
Monthly RSI	52.86
Open price	CAD 0.47
Position in 52-week range	0%
Previous close	CAD 0.47
Price vs 150-day SMA	-16.97%
Price vs 20-day SMA	-12.11%
Price vs 200-day SMA	-9.95%
Price vs 50-day SMA	-14.4%
Relative volume	0.69
RSI	29.31
Sharpe ratio	0.79
Sharpe ratio (3Y)	0.63
Sharpe ratio (5Y)	0.59
Sortino ratio	1.35
Sortino ratio (3Y)	1.03
Sortino ratio (5Y)	1.05
Volume	4.8K
Weekly RSI	39.07
YTD price change	-4.26%
YTD total return	-4.26%

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	49M
Shares change (QoQ)	1.21%
Shares change (YoY)	11.57%
Shares held by insiders	12.49%

Deeper analysis on CSE/BUX

14 sections in the full report · jump straight to what you need

Forecast

Base and Bull forecast paths with report-date return framing.

→

Valuation

Fair-value bridge, DCF, owner earnings, and peer multiples.

→

Sensitivity

Cost-of-equity and terminal-growth stress table.

→

Risks

Kill scenarios, soft-pass flags, and downside catalysts.

→

Earnings

Next earnings setup and beat / inline / miss thresholds.

→

Position sizing

Entry, exit, conviction, and quarterly monitoring rules.

→

Financials

Revenue, margins, cash flow, and balance-sheet context.

→

Peers

Relative valuation and profitability against the cohort.

→

Moat

Economic-profit evidence and competitive advantage risk.

→

Industry cycle

Sector phase, capital cycle, and secular tailwinds.

→

Frequently asked questions

About this CSE/BUX report

Is a complete CSE/BUX research report available?

No complete published report is available for cse/BUX (CSE/BUX) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

CSE/BUX (CSE/BUX)

Price

Financial snapshot

Fair-value bridge

Latest news · CSE/BUX

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All CSE/BUX indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on CSE/BUX

Frequently asked questions